Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Chemours Company (NY: CC )

21.00 -0.10 (-0.47%)
Official Closing Price Updated: 7:00 PM EST, Dec 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Chemours Company

< Previous 1 2 3 4 5 6 Next >
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022
Upgrades 
Via Benzinga
Analyst Ratings for Chemours
Chemours (NYSE:CC) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Expert Ratings for Chemours
Analysts have provided the following ratings for Chemours (NYSE:CC) within the last quarter: 
Via Benzinga
3 Undervalued Cruise Stocks to Buy Now
These undervalued cruise stocks have bounced back exceedingly well from the pandemic-led weakness and are benefitting from pent-up demand. 
Via InvestorPlace
Analyst Ratings for Chemours
Chemours (NYSE:CC) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2022
Upgrades 
Via Benzinga
McDonald's Price Target Cut By This Analyst, Plus Cowen Predicts $362 For Domino's Pizza
Citigroup cut McDonald's Corporation (NYSE: MCD) price target from $275 to $246. McDonald's shares rose 0.5% to $245.00 in pre-market trading. 
Via Benzinga
Spero Therapeutics To Rally Around 240%? Plus This Analyst Slashes PT On Salesforce
Evercore ISI Group raised the price target on Spero Therapeutics, Inc. (NASDAQ: SPRO) from $2 to $8. Evercore ISI Group analyst Josh Schimmer also upgraded the stock from In-Line to Outperform. Spero... 
Via Benzinga
Expert Ratings for Chemours
Within the last quarter, Chemours (NYSE:CC) has observed the following analyst ratings: 
Via Benzinga
New Report: Chemours
Chemours' price per share was $32.30 as of Friday's market close. One year ago its price was $29.02. 
Via Talk Markets
UnitedHealth To Rally 24%? Here Are 5 Other Price Target Changes For Thursday
Raymond James raised the price target on UnitedHealth Group Incorporated (NYSE: UNH) from $620 to $635. Raymond James analyst John Ransom maintained the stock with a Strong Buy rating. UnitedHealth... 
Via Benzinga
Chemours, Alcoa And Other Big Losers From Wednesday
U.S. stocks closed lower with the Dow Jones dropping more than 500 points on Tuesday. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
UBS Maintains Neutral Rating for Chemours: Here's What You Need To Know
UBS has decided to maintain its Neutral rating of Chemours (NYSE:CC) and raise its price target from $35.00 to $37.00. Shares of Chemours are trading up 3.55% over the last 24 hours, at $36.14 per... 
Via Benzinga
5 Analysts Have This to Say About Chemours
Over the past 3 months, 5 analysts have published their opinion on Chemours (NYSE:CC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's... 
Via Benzinga
Recap: Chemours Q2 Earnings
Chemours (NYSE:CC) reported its Q2 earnings results on Thursday, July 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Chemours beat estimated earnings by... 
Via Benzinga
How Does The Need Of Marketization Of HFCVs Impact PEM Industry?
As carbon neutral is becoming a consensus, the marketization of HFCVs is accelerating all over the world with its zero-carbon emission. 
Via Talk Markets
7 Small-Cap Stocks to Buy in July 2022
These are the best small-cap stocks to buy for July 2022. ARCH, AVUV, CEIX, COUR, DVAX, FATE, and TENB can make great investments. 
Via InvestorPlace
The Dynamics Behind Carnival's Q2 Earnings Rally
When an issue is in an extended downtrend and rallies off an earnings report, the next task is to determine if the rally will continue. That is what shareholders of Carnival Corp (NYSE: CC) were... 
Via Benzinga
Analyst: As Chemical Sector Takes A Hit, Here Are The 3 Best Stocks To Buy
As the commodity market shifts to an environment of stagflation and U.S. economic recession risks rise, Bank of America adjusted its coverage of chemical stocks on Tuesday. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2022
Upgrades 
Via Benzinga
3 No-Brainer Stocks to Buy for May
Stock investing is not easy but these 3 no-brainer stocks to buy based on their latest earnings have increased their odds of performing well in May. 
Via InvestorPlace
80 Biggest Movers From Yesterday
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 93.1% to close at $6.45 on Tuesday on above-average volume. XORTX Therapeutics Inc. (NASDAQ: XRTX) gained 59.1% to... 
Via Benzinga
41 Stocks Moving In Tuesday's Mid-Day Session
Gainers SoundHound AI, Inc. (NASDAQ: SOUN) shares jumped 47.4% to $16.13. The company recently completed a SPAC merger deal last week and began trading on Thursday. Sonoma... 
Via Benzinga
Chemours: Q1 Earnings Insights
Chemours (NYSE:CC) reported its Q1 earnings results on Monday, May 2, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Chemours beat estimated earnings by 58.7%,... 
Via Benzinga
Overview Of Value Stocks In The Basic Materials Sector
The Meaning Behind Value Stocks A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may... 
Via Benzinga
Earnings Scheduled For May 2, 2022
Companies Reporting Before The Bell • New Gold (AMEX:NGD) is estimated to report quarterly earnings at $0.03 per share on revenue of $212.42 million. 
Via Benzinga
IBD Rating Upgrades: The Chemours Company Flashes Improved Relative Price Strength
The Chemours Company shows rising price performance, earning an upgrade to its IBD Relative Strength Rating 
Via Investor's Business Daily
78 Biggest Movers From Friday
Gainers Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) surged 26% to close at $2.24. Y-mAbs reported completion of pre-BLA meeting with the FDA for Omburtamab. China Online Education... 
Via Benzinga
41 Stocks Moving In Friday's Mid-Day Session
Gainers Modular Medical, Inc. (NASDAQ: MODD) shares climbed 34.5% to $4.99 following its recent uplisting to the Nasdaq Capital Market on Thursday. Kaival Brands Innovations... 
Via Benzinga
Chemours: Q4 Earnings Insights
Chemours (NYSE:CC) reported its Q4 earnings results on Thursday, February 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Chemours missed estimated earnings by... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.